|2016 Central Clinical School's Bachelor of Medical Science (Honours) information evening. Drs Daphne Vogiagis and Geraldine Ooi are talking with Mr James Lee and a potential student at the Department of Surgery table. Both AMREP* schools are running the information night this year:|
Thursday 13 July, 2017 6.00pm to 8.00pmAMREP Education Centre (see map)
80 Commercial Road, Melbourne, 3004.
The AMREP schools (Central Clinical School and School of Public Health and Preventive Medicine) will showcase their research expertise and what they can offer to a BMedSc(Hons) candidate. You can meet and discuss research projects with potential supervisors after the main presentation. Refreshments will be provided.
To RSVP, please register your attendance.
See more: CCS and SPHPM BMedSc(Hons) programs
*AMREP: Alfred Medical Research and Education Precinct
19 May 2017
|Paul Gill is presenting on how bacterial|
DNA can protect airways in allergic
inflammation, Thu 25 May 2017
Central Clinical School (CCS) has regular seminar series and postgraduate presentations. Event notices are posted on the CCS Events calendar.
CCS staff & students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS intranet's Announcements page. Various departments have their own calendars.
See CCS seminar index: www.med.monash.edu.au/cecs/events/seminars.html
What's on for 22-26 May
|Mon||22/05/2017||►||12:30||Alfred Psychiatry Grand Round: Dr Ellie Harrison|
|Tue||23/05/2017||►||11:00||ACBD scientific meeting: Dr Gemma Kelly|
|Wed||24/05/2017||►||11:30||Immunology Seminar: Justine Mintern (University of Melbourne)|
|Thur||25/05/2017||►||11:30||Cutting Edge Journal Club: Paul Gill|
|►||12:00||Alfred Grand Rounds: Palliative Care|
Save the dateThu 13/07/2017 AMREP Bachelor of Medical Science (Honours) information evening
Mon 31/07/2017 Translational Research symposium: RSVP
|Professor Andrew Spencer is|
last author on two papers this
week on multiple myeloma
|Your brain distorts your perception|
of yourself in BDD.
Body Dysmorphic Disorder (BDD) is a condition in which the individual is preoccupied or excessively concerned by what they see as flaws in their appearance, whether it’s the size or shape of their nose, the symmetry of their cheekbones or an imaginary defect elsewhere on their body.
17 May 2017
|Saudi Arabia records over half a million road accidents each year. |
Internationally, trauma is the leading cause of death in the first four decades of life and the second most frequent cause of deaths in all age groups. This has prompted the World Health Organisation (WHO) to declare the ‘Decade of Action’ (2011-2020) on road safety.
|Dr Be'eri Niego (right) with honours|
student Mr Felix Lee in
Prof Rob Medcalf's lab.
Around the world, the race is on to find new ways to treat ischaemic (blood clot-derived) stroke. Some of these efforts are aimed at increasing the safety of the main treatment currently in use, the clot-busting enzyme tissue-type Plasminogen Activator (t-PA). t-PA is effective in improving recovery if administered quickly – within 4.5 hours of a stroke. But as it dissolves the clots that cause stroke, t-PA also weakens the blood vessels in the brain that form what’s called the blood-brain barrier (BBB), increasing the risk of bleeding in the brain, potentially lethally, which limits the therapy’s use.
16 May 2017
|Professor Kathryn North AM|
The Keynote speaker for the event is Professor Kathryn North AM, Director of the Murdoch Children's Research Institute, Director of the Victorian Clinical Genetics Service and the David Danks Professor of Child Health Research at the University of Melbourne.
|The TR Symposium is coming up soon!|
A Young Investigator poster competition will be held, with a winning prize of $500. The competition is open to graduate student and early career researchers, who are within 5 years of completing their PhD. Entries now invited.
|Professor Paul Myles with Minister Greg Hunt MP at the award|
ceremony, Friday 19 May 2017. Photo: Sophie Wallace
Professor Myles is the head of the Department of Anaesthesia and Perioperative Medicine at Monash and Alfred. He has led a number of large studies involving many centres and thousands of patients to investigate the safety of the anaesthetic drug nitrous oxide, whether patients taking aspirin can safely continue up to and post-surgery, and the safety of an anti-bleeding drug called tranexamic acid (TXA). Results of these international multi-centre trials run across several countries have been published in the prestigious journals The New England Journal of Medicine (NEJM) (2016 and 2017) and The Lancet (2014).
The trial for which Professor Myles received the ACTA award is Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) – results for which were published in NEJM last year.
The ATACAS team collaborated internationally with 30 hospitals across seven countries with over 4,600 patients participating. The results show that TXA could almost halve the number of people who suffer complications with bleeding following open heart and other major surgery.
“The results were very clear-cut and reassuring,” said Professor Myles. “TXA does not increase thrombosis after open heart surgery. Furthermore, there was strong evidence that TXA nearly halved the risk of serious bleeding complications – meaning less bleeding, fewer blood transfusions and far less need for emergency re-operation following surgery.
“The findings mean that almost every heart surgery patient can now be treated with TXA, and that we can safely use a higher dose than previously. Use of TXA can also be safely expanded to prevent bleeding with other kinds of major surgery, such as knee and hip replacements, trauma surgery and spinal surgery, operations where TXA is not much used at present.”
Currently, each year about 15,000 Australians who have heart surgery (40 per cent of the total) need blood transfusions, and up to 1000 need a second, emergency surgery. “Routine use of TXA can halve both those figures,” Professor Myles said.
The ACTA award recognises the importance of the research and its direct influence on improving patient outcomes globally.
This talk was given at the International Society for Cellular Therapy, Annual meeting London 2017. Shiva described a Phase I clinical trial outcomes on Cultured epidermal sheet autografts (CEA) on a fibrin carrier that was carried out at the Alfred 2013-2016.
15 May 2017
|Heidi Fettke won the Nairn prize for top|
Honours student in 2016
Nairn Prize: top Honours student
The Nairn Prize in Immunology, named after the Department's founding chairman, Professor Richard Nairn, is given to the top Immunology Honours student completing his or her project at Monash and coordinated within the Department of Immunology and Pathology.
|L-R: Dr Sara Prickett, Professor Robyn O’Hehir |
and Emeritus Professor Jenny Rolland have
hworked together for years on the peanut allergy
research and are co-founders of Aravax P/L.
Professor Robyn O’Hehir is Professor/Director of the Department of Allergy, Immunology and Respiratory Medicine at Alfred Health and Monash University. Her research team, co-led by Professor Jennifer Rolland, over several years identified the critical components of the peanut allergy therapy now being developed by Aravax, an Australian spinout biotechnology company.